My Size, Inc (MYSZ) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MYSZ SEC filings page.
My Size, Inc (MYSZ) reported $9.4M in revenue for fiscal year 2025, up 13.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
My Size has growing revenue but remains cash-consuming: reported earnings are disconnected from operations, and financing fills the gap.
In FY2025, net income of$5.9M sat beside operating cash flow of-$5.1M ; FY2024 showed the same split. That combination is consistent with material non-operating gains or accounting effects, not cash-generating operating profitability.
Gross margin narrowed from
The company received
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of My Size, Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
My Size, Inc held $2.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $5.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and My Size, Inc scores 19/100 among other emerging companies.
My Size, Inc had 5M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and My Size, Inc scores 77/100 among other emerging companies.
My Size, Inc spent $597K on research and development in fiscal year 2025, which was 4.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and My Size, Inc scores 21/100 among other emerging companies.
My Size, Inc reported revenue of $9.4M in fiscal year 2025, against $8.3M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and My Size, Inc scores 61/100 among other emerging companies.
My Size, Inc's operations used $5.1M of cash in fiscal year 2025, against $3.1M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and My Size, Inc scores 55/100 among other emerging companies.
My Size, Inc's cash, cash equivalents and investments came to $2.3M at the end of fiscal year 2025, against $5.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and My Size, Inc scores 42/100 among other emerging companies.
My Size, Inc scores -9.98, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($843K) relative to total liabilities ($5.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
My Size, Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, My Size, Inc used $0.88 of operating cash (-$5.1M OCF vs $5.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
My Size, Inc generated $3.1M in revenue in Q2 2026. This represents an increase of 53.0% from the same quarter a year earlier. Against the prior quarter it is up 28.2%.
My Size, Inc's EBITDA was -$1.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 202.5% from the same quarter a year earlier. Against the prior quarter it is down 28.5%.
My Size, Inc reported -$1.8M in net income in Q2 2026. This represents a decrease of 289.3% from the same quarter a year earlier. Against the prior quarter it is down 18.7%.
Cash & Balance Sheet
My Size, Inc generated $24K in free cash flow in Q2 2026, representing cash available after capex. Against the prior quarter it is up 101.1%.
My Size, Inc held $453K in cash against $775K in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
My Size, Inc's gross margin was 31.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 24.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.6 percentage points.
My Size, Inc's operating margin was -56.1% in Q2 2026, reflecting core business profitability. This is down 26.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.
My Size, Inc's net profit margin was -57.1% in Q2 2026, showing the share of revenue converted to profit. This is down 34.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.6 percentage points.
My Size, Inc's ROE was -74.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 68.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 37.3 percentage points.
Capital Allocation
My Size, Inc invested $375K in research and development in Q2 2026. This represents an increase of 164.1% from the same quarter a year earlier. Against the prior quarter it is up 56.9%.
My Size, Inc invested $1K in capex in Q2 2026, funding long-term assets and infrastructure. Against the prior quarter it is down 97.8%.
Not reported for Q2 2026.
MYSZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1M+53.0% | $2.4M+61.9% | $66K-95.5% | $2.6M+39.9% | $2.0M+1.4% | $1.5M-50.4% | $1.5M-48.6% | $1.8M-14.7% |
| Cost of Revenue | $2.1M+137.8% | $1.5M+37.3% | N/A | $1.6M+49.1% | $882K-11.4% | $1.1M-40.8% | $1.1M-29.6% | $1.0M+34.4% |
| Gross Profit | $973K-13.4% | $940K+123.8% | N/A | $1.0M+27.6% | $1.1M+14.2% | $420K-64.9% | $352K-72.1% | $791K-42.5% |
| R&D Expenses | $375K+164.1% | $239K+191.5% | N/A | $131K+47.2% | $142K+8.4% | $82K-37.9% | $77K-52.8% | $89K-63.2% |
| SG&A Expenses | $1.2M+31.1% | $1.2M+46.5% | N/A | $1.0M+56.3% | $904K+0.6% | $831K-19.6% | $796K+4.6% | $640K-50.3% |
| Operating Income | -$1.7M-193.9% | -$1.4M-32.6% | N/A | -$1.4M-3.8% | -$586K+33.2% | -$1.1M+1.0% | -$690K+56.6% | -$1.3M-18.2% |
| EBITDA | -$1.6M-202.5% | -$1.2M-21.1% | N/A | -$1.2M-6.3% | -$524K+39.7% | -$1.0M-3.1% | -$636K+58.0% | -$1.1M-11.7% |
| Interest Expense | N/A | $13K+550.0% | N/A | N/A | N/A | $2K-75.0% | N/A | N/A |
| Net Income | -$1.8M-289.3% | -$1.5M-39.2% | N/A | -$1.3M-2.7% | -$450K+53.3% | -$1.1M-4.3% | $7.3M+658.3% | -$1.3M-14.8% |
| EPS (Basic) | -$2.92-121.2% | -$0.31+39.2% | -$0.87-383.3% | -$0.40+68.0% | -$1.32-3.1% | -$0.51+72.9% | -$0.18+93.7% | -$1.25+64.5% |
| EPS (Diluted) | -$2.92 | -$0.31 | -$0.87-383.3% | -$0.40 | -$1.32 | -$0.51 | -$0.18 | -$1.25 |
| Diluted Shares (Avg) | 600,560 | 5M | N/A | 3M | 386,467 | 2M | N/A | 1M |
Not reported in any period shown, so not listed: Income Tax.
MYSZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5M-34.3% | $8.5M-3.0% | $10.2M+1.4% | $11.7M+65.7% | $9.9M+23.1% | $8.8M+31.2% | $10.1M+11.9% | $7.0M-37.2% |
| Current Assets | $4.3M-49.3% | $6.2M-20.7% | $7.7M-14.7% | $9.1M+52.7% | $8.4M+35.6% | $7.8M+64.2% | $9.1M+36.9% | $5.9M-26.3% |
| Cash & Equivalents | $453K-89.4% | $654K-82.3% | $2.3M-52.8% | $4.5M+89.5% | $4.3M+33.8% | $3.7M+225.3% | $4.9M+123.1% | $2.4M-35.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.0M-32.4% | $3.4M+36.2% | $3.0M+8.5% | $3.3M+49.5% | $2.9M+61.8% | $2.5M+17.2% | $2.8M-2.9% | $2.2M-6.6% |
| Accounts Receivable | $927K+132.9% | $890K+66.7% | $1.2M+336.7% | $506K+54.7% | $398K+21.0% | $534K+31.5% | $278K-54.8% | $327K-52.6% |
| Long-Term Investments | $2K-85.7% | $2K-85.7% | $2K-71.4% | $14K+100.0% | $14K+40.0% | $14K+27.3% | $7K+16.7% | $7K-73.1% |
| Goodwill | $633K+345.8% | $634K+376.7% | $640K+381.2% | $686K+423.7% | $142K+6.8% | $133K-82.1% | $133K-82.5% | $131K-90.6% |
| Total Liabilities | $4.1M+69.0% | $4.5M+66.6% | $5.0M+60.2% | $4.4M+69.3% | $2.4M+5.7% | $2.7M-6.7% | $3.1M-26.0% | $2.6M-51.2% |
| Current Liabilities | $3.3M+52.9% | $3.7M+41.7% | $4.1M+37.9% | $3.3M+39.7% | $2.2M+2.5% | $2.6M-4.1% | $3.0M-22.7% | $2.4M-47.8% |
| Non-Current Liabilities | $831K+189.5% | $868K+543.0% | $916K+494.8% | $1.0M+442.3% | $287K+38.0% | $135K-38.1% | $154K-59.3% | $189K-72.9% |
| Long-Term Debt | $775K+742.4% | $788K+492.5% | $831K+469.2% | $832K+370.1% | $92K-52.3% | $133K-39.0% | $146K-41.4% | $177K-34.0% |
| Total Equity | $2.3M-68.3% | $4.0M-34.4% | $5.2M-25.4% | $7.3M+63.7% | $7.4M+30.2% | $6.0M+60.6% | $6.9M+45.9% | $4.5M-24.8% |
| Retained Earnings | -$73.0M-11.6% | -$71.2M-9.7% | -$69.7M-9.2% | -$66.7M-5.6% | -$65.4M-5.7% | -$64.9M-6.6% | -$63.9M-6.7% | -$63.2M-7.8% |
MYSZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $25K+102.4% | -$2.1M-63.2% | -$2.3M-310.5% | -$500K-11.9% | -$1.0M-57.5% | -$1.3M+10.5% | -$569K+52.4% | -$447K+64.8% |
| Depreciation & Amortization | $137K+121.0% | $173K+311.9% | $92K+70.4% | $146K-13.1% | $62K+675.0% | $42K-50.0% | $54K-28.9% | $168K+95.3% |
| Stock-Based Compensation | $88K+91.3% | $90K+309.1% | N/A | N/A | $46K | $22K-84.1% | N/A | N/A |
| Capital Expenditures | $1K | $46K | $0 | $0 | N/A | N/A | N/A | N/A |
| Free Cash Flow | $24K | -$2.1M | -$2.3M | -$500K | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$1K | -$46K | $0+100.0% | -$142K | N/A | N/A | -$7K | $0 |
| Financing Cash Flow | -$209K-111.6% | $453K+376.8% | $285K-90.4% | $820K+344.8% | $1.8M-29.7% | $95K-76.7% | $3.0M+3191.7% | -$335K-109.2% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MYSZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7%-24.3pp | 39.3%+10.9pp | N/A | 39.2%-3.8pp | 56.0%+6.3pp | 28.4%-11.7pp | 24.2%-20.4pp | 43.0%-20.8pp |
| Operating Margin | -56.1%-26.9pp | -58.7%+12.9pp | N/A | -52.7%+18.3pp | -29.2%+15.1pp | -71.7%-35.8pp | -47.4%+8.8pp | -71.0%-19.8pp |
| Net Margin | -57.1%-34.6pp | -61.7%+10.0pp | N/A | -51.9%+18.8pp | -22.4%+26.3pp | -71.7%-37.6pp | 500.0% | -70.7%-18.2pp |
| Return on Equity | -74.7%-68.6pp | -37.3%-19.8pp | N/A | -18.3%+10.9pp | -6.1%+10.9pp | -17.6%+9.5pp | 105.3%+132.8pp | -29.2%-10.1pp |
| Return on Assets | -27.0%-22.5pp | -17.4%-5.3pp | N/A | -11.5%+7.0pp | -4.6%+7.5pp | -12.1%+3.1pp | 72.3%+86.8pp | -18.5%-8.4pp |
| Current Ratio | 1.29-2.6x | 1.69-1.3x | 1.87-1.2x | 2.73+0.2x | 3.89+1.0x | 3.02+1.3x | 3.03+1.3x | 2.49+0.7x |
| Debt-to-Equity | 0.33+0.3x | 0.20+0.2x | 0.16+0.1x | 0.11+0.1x | 0.010.0x | 0.020.0x | 0.020.0x | 0.040.0x |
| Asset Turnover | 0.47+0.3x | 0.28+0.1x | 0.01-0.1x | 0.220.0x | 0.200.0x | 0.17-0.3x | 0.14-0.2x | 0.26+0.1x |
| FCF Margin | 0.8% | -88.3% | -3539.4% | -19.4% | N/A | N/A | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| My Size, Inc MYSZ | FY2025 | $9.4M | $5.9M | 62.5% | $843K | 46/100 |
| Freight Technologies, Inc. FRGT | FY2025 | $13.1M | -$7.9M | -60.5% | $168K | 32/100 |
| Auddia Inc. AUUD | FY2025 | $0 | -$7.7M | N/A | $6.2M | — |
| Treasure Global Inc. TGL | FY2025 | $2.3M | -$23.4M | N/A | $2.2M | 25/100 |
| Urgent.ly Inc. ULY | FY2025 | $129.2M | -$20.4M | -15.8% | $11.8M | 43/100 |
| Youxin Technology Ltd YAAS | FY2025 | $539K | -$9.6M | N/A | $17.0M | — |
Where My Size, Inc Ranks
Frequently Asked Questions
What is My Size, Inc's annual revenue?
My Size, Inc (MYSZ) reported $9.4M in total revenue for fiscal year 2025. This represents a 13.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is My Size, Inc's revenue growing?
My Size, Inc (MYSZ) revenue grew by 13.4% year-over-year, from $8.3M to $9.4M in fiscal year 2025.
Is My Size, Inc profitable?
Yes, My Size, Inc (MYSZ) reported a net income of $5.9M in fiscal year 2025, with a net profit margin of 62.5%.
What is My Size, Inc's EBITDA?
My Size, Inc (MYSZ) had EBITDA of -$5.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does My Size, Inc have?
As of fiscal year 2025, My Size, Inc (MYSZ) had $2.3M in cash and equivalents against $831K in long-term debt.
What is My Size, Inc's gross margin?
My Size, Inc (MYSZ) had a gross margin of 32.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is My Size, Inc's operating margin?
My Size, Inc (MYSZ) had an operating margin of -61.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is My Size, Inc's net profit margin?
My Size, Inc (MYSZ) had a net profit margin of 62.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is My Size, Inc's return on equity (ROE)?
My Size, Inc (MYSZ) has a return on equity of 113.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is My Size, Inc's free cash flow?
My Size, Inc (MYSZ) recorded an outflow of $5.2M in free cash flow during fiscal year 2025. This represents a -66.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is My Size, Inc's operating cash flow?
My Size, Inc (MYSZ) recorded an outflow of $5.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are My Size, Inc's total assets?
My Size, Inc (MYSZ) had $10.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are My Size, Inc's capital expenditures?
My Size, Inc (MYSZ) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does My Size, Inc spend on research and development?
My Size, Inc (MYSZ) invested $597K in research and development during fiscal year 2025.
What is My Size, Inc's current ratio?
My Size, Inc (MYSZ) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.
What is My Size, Inc's debt-to-equity ratio?
My Size, Inc (MYSZ) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is My Size, Inc's return on assets (ROA)?
My Size, Inc (MYSZ) had a return on assets of 57.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is My Size, Inc's P/E ratio?
My Size, Inc (MYSZ) trades at 0.1x earnings, its market capitalization divided by net income of $5.9M net income, FY2025. The market capitalization is $843K as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is My Size, Inc's price-to-sales ratio?
My Size, Inc (MYSZ) trades at 0.1x sales, its market capitalization divided by revenue of $8.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $843K as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does My Size, Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, My Size, Inc (MYSZ) held $2.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.1M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is My Size, Inc's Altman Z-Score?
My Size, Inc (MYSZ) has an Altman Z-Score of -9.98, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is My Size, Inc's Piotroski F-Score?
My Size, Inc (MYSZ) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are My Size, Inc's earnings high quality?
For every $1 of reported earnings, My Size, Inc (MYSZ) used $0.88 of operating cash (-$5.1M OCF vs $5.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is My Size, Inc?
My Size, Inc (MYSZ) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.